Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 314.20
+14.20 (4.73%)
At close: Nov 26, 2025
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.33 trillion as of November 26, 2025. Its market cap has decreased by -58.79% in one year.
Market Cap
1.33T
Enterprise Value
1.40T
Revenue
315.60B
Ranking
n/a
PE Ratio
12.86
Stock Price
314.20
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.33T, an increase of 2,797.78%. That is a compound annual growth rate of 12.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 1.33T | -51.92% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | 986.61B | 8.50% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coloplast | 130.49B |
| Genmab | 123.50B |
| ALK-Abelló | 50.48B |
| Demant | 46.31B |
| H. Lundbeck | 41.97B |
| Zealand Pharma | 38.03B |
| Ambu A/S | 23.50B |
| Bavarian Nordic | 14.56B |